Skip to main content
. 2018 Feb 26;13(2):e0193438. doi: 10.1371/journal.pone.0193438

Table 2. GALC mutational analysis.

Allele 1 Allele 2
Promoter Exonic Variants Synonymous Promoter Exonic Variants Synonymous
AD c.-287 G>A p.Ile562Thr p.Q328Q
AD c.-287 G>A p.Ile562Thr p.D110D c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G
AD p.Ile562Thr p.S450S p.Ile562Thr p.S450S
AD c.-287 G>A p.Ile562Thr p.Q328Q
AD p.Q328Q p.Q328Q
AD c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Q328Q
AD c.-287 G>A p.Ile562Thr p.Q328Q
AD p.Q328Q p.Q328Q
AD p.Ile562Thr p.S450S p.Ile562Thr p.S450S
AD c.-287 G>A p.Ile562Thr p.Q328Q
PD p.Ile562Thr p.S450S p.Q328Q
PD p.Ile562Thr p.S450S p.Q328Q
PD p.Q328Q p.Q328Q
PD p.Ile562Thr p.S450S p.Q328Q
PD p.Arg184Cys p.Ile562Thr p.S450S p.Q328Q
PD p.Arg184Cys p.Ile562Thr p.S450S p.Q328Q
PD p.Ile562Thr p.S450S p.Q328Q
PD c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Q328Q
PD p.Ile562Thr p.S450S p.Ile562Thr p.S450S
PD p.Q328Q p.Q328Q
PD c.-287 G>A p.Ile562Thr p.S450S p.Ile562Thr p.S450S
PD p.Arg184Cys p.Ile562Thr p.Phe596Ser p.S450S p.Arg184Cys p.Ile562Thr p.S450S
PD c.-287 G>A   p.Trp132* c.-287 G>A p.Q328Q
PD p.Q328Q p.Q328Q
PD c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
PD p.Ile562Thr p.S450S p.Ile562Thr p.S450S
PD p.Ile562Thr p.S450S p.Q328Q
PD c.-287 G>A p.Ile562Thr p.D110D p.Q328Q
PD c.-287 G>A p.Ile562Thr p.D110D p.Q328Q
PD p.Ile562Thr p.S450S p.Q328Q
Control p.Q328Q p.Q328Q
Control p.Arg184Cys p.Ile562Thr p.S450S p.Q328Q
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G c.-287 G>A p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Q328Q
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Q328Q
Control p.Arg184Cys p.Ile562Thr p.S450S p.Q328Q
Control c.-287 G>A p.Ile562Thr p.S450S p.Ile562Thr p.S450S
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Ile562Thr p.S450S
Control c.-287 G>A p.Ile562Thr p.Q328Q
Control c.-287 G>A p.Ile562Thr
Control p.Arg184Cys p.Ile562Thr p.S450S p.Arg184Cys p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Ile562Thr p.S450S
Control c.-287 G>A p.L5L/L133L p.Ile562Thr p.S450S
Control p.Arg184Cys p.Ile562Thr p.S450S p.Q328Q
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Q328Q
Control p.Ile562Thr p.S450S p.Q328Q
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.Thr112Ala p.A14A/G25G c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G
Control p.Q328Q p.Q328Q
Control p.Ile562Thr p.S450S p.Q328Q
Control c.329 -8_10 del p.Ile562Thr p.S450S p.Q328Q
Control c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Ile562Thr p.S450S
Control p.Ile562Thr p.S450S p.Q328Q
KD c.-148 T>C p.Ala21Pro p.Asp248Asn p.A14A/G25G p.Arg184Cys g.30 Kb del
KD p.Arg184Cys g.30 Kb del p.Arg184Cys g.30 Kb del
KD c.-148 T>C p.Asp248Asn p.Thr529Met p.A14A/G25G     p.Tyr173Leu p.Q328Q
KD Late-onset p.Ser23* p.Arg184Cys p.Ile562Thr p.S450S   p.Met117Leu p.Ile562Thr p.S450S
Control Infant c.1834+5 G>C p.Ala641Thr p.L359L/T540T/V556V p.Ile562Thr p.S450S

DNA was extracted from tissues of Alzheimer’s, Parkinson’s, Krabbe, and healthy diagnosed patients. DNA was sequenced for SNPs present in GALC, which are listed in the table for each patient. GALC mutations causing severely diminished activity are listed in bold, which were confirmed in all Krabbe patients. An additional 4 patients were identified as carriers (heterozygous) for severe/mild mutations to GALC, 2 within patient diagnosed with Parkinson’s, and 2 within patients diagnosed without any neurological disorder.